Benign prostatic hyperplasia is a very common benign disorder of males
. Its prevalence increases with advancing age, Diagnosis rests on a pa
ttern of subjective symptoms and objective findings, since no diagnost
ic criteria are available. The International Consensus Committee on be
nign prostatic hyperplasia has issued recommendations about the evalua
tion and management of this disorder, Pharmacotherapy, where appropria
te, relies on alpha-blocking agents, 5 alpha-reductase inhibitors, and
phytotherapy, The conventional surgical procedures are transurethral
resection of the prostate and transvesical adenomectomy. Local applica
tion of heat and laser therapy are being evaluated.